NeuroVive - Interim Report January-June 2016

August 18, 2016 |

1 min read

STOCKHOLM--(BUSINESS WIRE)--Regulatory News:

NeuroVive Pharmaceutical (STO:NVP)

Business operations

Important events April-June 2016

· Fully subscribed rights issue amounting to approximately SEK 77.3 million after issue expenses

Earnings Europe

MORE ON THIS TOPIC

Successful businessman standing in front of multiple pathways, making a decision for the right move. A symbol of great investment and positive progress in the development of business. stock illustration

Mergers & acquisitions

Lilly-Verve Proxy Filing Reveals Tumult After Departure of FDA’s Marks

June 26, 2025

·

4 min read

·

Annalee Armstrong

Strong Business Partnership and teamwork metaphor as two different groups joining together with a handshake represented by trees and stronk roots.

Deals

Longevity Biotech Takes Root on Nasdaq With $180M SPAC Deal

June 26, 2025

·

1 min read

·

Annalee Armstrong

World heart day. Sketch style human heart. Retro halftone hands reaching out to each other. Modern collage. Valentines day banner. Healthcare medical concept. Healthy lifestyle.

Cardiovascular disease

Novartis Makes Potential $750M+ Bet Per Cardiovascular Disease Target in Another Flagship Pact

June 26, 2025

·

2 min read

·

Tristan Manalac

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Bayer’s BlueRock Lays Off 50 in Streamlining Effort

June 26, 2025

·

148 min read

·

BioSpace Editorial Staff